Organigram Holdings Inc. reported earnings results for the first quarter ended November 30, 2022. For the first quarter, the company reported sales was CAD 60.88 million compared to CAD 44.35 million a year ago. Revenue was CAD 43.32 million compared to CAD 30.38 million a year ago.

Net income was CAD 5.33 million compared to net loss of CAD 1.31 million a year ago. Basic earnings per share from continuing operations was CAD 0.068 compared to basic loss per share from continuing operations of CAD 0.016 a year ago. Diluted earnings per share from continuing operations was CAD 0.068 compared to diluted loss per share from continuing operations of CAD 0.016 a year ago.